![Expert Q&A: The Latest in Breath Biopsy](https://www.g2intelligence.com/wp-content/uploads/2023/08/Sept23.DTET_.Owlstone.LatestinBreathBiopsy-iStock-1217066043_1100x800-1080x675.jpg)
Expert Q&A: The Latest in Breath Biopsy
Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.
Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.
Congress is renewing its previous efforts to make Medicare reimbursement of pharmacy testing permanent—here’s what that could mean for labs.
The inexpensive POC device is a biosensor that performs COMT genotyping as a biomarker for hypnotizability.
Principal investigator discusses a new research initiative to create a low-cost, rapid HIV self-test.
The new guidelines address issues with false negatives and positives from POC testing for fertility and reproductive health.